Skip to main content
Clinical Trials/PACTR202006473495513
PACTR202006473495513
Other
Phase 1

The comparative effect of dry needling versus ultrasound therapy in the treatment of active rhomboid trigger points.

niversity of Johannesburg Health Science Chiroparctic Department0 sites30 target enrollmentFebruary 3, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Musculoskeletal Diseases
Sponsor
niversity of Johannesburg Health Science Chiroparctic Department
Enrollment
30
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Johannesburg Health Science Chiroparctic Department

Eligibility Criteria

Inclusion Criteria

  • Participants are either male or female aged between 18\-50 years old –reason for a minimum age of 18 so that parental consent is avoided, and participants can sign their own consent forms, and the maximum age of 50 is to avoid degenerative changes that may be present.
  • Participants presenting with active rhomboid trigger point pain
  • Rhomboid Trigger point diagnosis according to the following criteria:
  • Presence of hyperirritable palpable nodule within a taut band of muscle.
  • Spot tenderness over the palpable nodule
  • With a pain referral along the vertebral border of scapula between the scapula and Paraspinal muscles. It may spread upwards to the spinous portion of the scapula and pain patterns resemble that of the levator scapulae muscle but without the neck component and without restriction to neck rotation.

Exclusion Criteria

  • Participants with any contraindication to ultrasound therapy obtained on case history and physical examination
  • Participants with any contraindications to dry needling obtained on case history and physical examination
  • Participants receiving any other form of treatment such as physiotherapy, other chiropractic treatment or any medication, such as muscle relaxants, analgesics or anti\-inflammatories that will interfere with the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials